OpenLB
Open Library of Bioscience
Advanced Search
Journal of clinical medicine
Apr 29, 2022;11 (9):

Acceptability of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening in a Cohort of Patients from Romania (Stage 2).

Mihaela Grigore, Ingrid-Andrada Vasilache, Petru Cianga, Daniela Constantinescu, Odetta Duma, Roxana Daniela Matasariu, Ioana-Sadiye Scripcariu
Author Information
  1. Mihaela Grigore: Department of Obstetrics and Gynecology, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.
  2. Ingrid-Andrada Vasilache: Department of Obstetrics and Gynecology, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania. ORCID
  3. Petru Cianga: Department of Immunology, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.
  4. Daniela Constantinescu: Department of Immunology, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.
  5. Odetta Duma: Department of Epidemiology, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.
  6. Roxana Daniela Matasariu: Department of Obstetrics and Gynecology, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.
  7. Ioana-Sadiye Scripcariu: Department of Obstetrics and Gynecology, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.
PMID: 35566630 DOI: 10.3390/jcm11092503

Abstract

(1) Background: Low patient’s adherence to conventional cervical cancer screening methods determined the need to take into consideration alternative approaches, and vaginal HPV self-sampling is one of them. We aimed to evaluate, using an online survey, the Romanian women’s acceptability of vaginal HPV self-sampling. (2) Methods: A 13-questions online survey was distributed on three Facebook groups, and the results were summarized. (3) Results: Despite of good educational background, 10.8% (n = 60) of the respondents did not know what a Pap smear is, and 33% (n = 183) were not informed about the free national cervical cancer screening program. Multivariate analysis revealed an increased likelihood of vaginal self-sampling acceptance among respondents who did not know about Pap test (OR: 7.80; 95%CI: 1.062−57.431; p = 0.021), national cervical cancer screening program (OR: 1.96; 95%CI: 1.010−3.806; p = 0.02), HPV infection (OR: 7.35; 95%CI: 3.099−17.449; p< 0.001) or HPV test (OR: 1.67; 95%CI: 0.950−2.948; p = 0.03). Moreover, women who did not previously undergo a cervical cancer screening program were more likely to accept the new screening method (OR: 1.62; 95%CI: 0.878−3.015; p = 0.04). (4) Conclusions: Our results showed high acceptability rates of vaginal HPV self-sampling among participants.

Keywords

HPV detection acceptability cervical cancer screening self-sampling

References

  1. Lancet Reg Health Eur. 2021 Nov 09;11:100235 [PMID: 34918001]
  2. Lancet Reg Health Am. 2022 Apr;8: [PMID: 35528707]
  3. Eur J Cancer. 2015 Nov;51(16):2375-85 [PMID: 26296294]
  4. Eur J Obstet Gynecol Reprod Biol. 2010 Jan;148(1):90-5 [PMID: 19910102]
  5. Med J Malaysia. 2019 Feb;74(1):8-14 [PMID: 30846655]
  6. J Low Genit Tract Dis. 2010 Oct;14(4):356-62 [PMID: 20885165]
  7. BMJ Open. 2016 Aug 04;6(8):e011022 [PMID: 27491667]
  8. J Glob Oncol. 2017 Jan 18;3(5):444-454 [PMID: 29094082]
  9. BMJ Glob Health. 2019 May 14;4(3):e001351 [PMID: 31179035]
  10. Eur J Cancer. 2009 Oct;45(15):2640-8 [PMID: 19695864]
  11. Int J Equity Health. 2021 Jul 29;20(1):175 [PMID: 34325727]
  12. J Natl Med Assoc. 2020 Apr;112(2):229-232 [PMID: 32278478]
  13. IARC Monogr Eval Carcinog Risks Hum. 2007;90:1-636 [PMID: 18354839]
  14. Women Health. 2021 Jan;61(1):83-94 [PMID: 33106125]
  15. Prev Med. 2014 Jul;64:108-13 [PMID: 24736093]
  16. Am J Obstet Gynecol. 2015 Jan;212(1):65.e1-5 [PMID: 24983684]
  17. Womens Health (Lond). 2021 Jan-Dec;17:17455065211017070 [PMID: 34032158]
  18. CA Cancer J Clin. 2021 May;71(3):209-249 [PMID: 33538338]
  19. Int J Environ Res Public Health. 2022 Feb 24;19(5): [PMID: 35270303]
  20. J Rural Health. 2022 Mar;38(2):409-415 [PMID: 34506669]
  21. J Prim Care Community Health. 2020 Jan-Dec;11:2150132720980612 [PMID: 33300414]
  22. Ann Intern Med. 2011 Nov 15;155(10):687-97, W214-5 [PMID: 22006930]
  23. Indian J Cancer. 2018 Oct-Dec;55(4):318-326 [PMID: 30829264]
  24. Int J Womens Health. 2015 Feb 02;7:149-54 [PMID: 25674016]
  25. Int J Womens Health. 2015 Nov 04;7:883-8 [PMID: 26604830]
  26. Asian Pac J Cancer Prev. 2015;16(17):7401-7 [PMID: 26625735]
  27. J Low Genit Tract Dis. 2019 Jul;23(3):193-199 [PMID: 30933030]
  28. Trop Med Int Health. 2019 Sep;24(9):1054-1063 [PMID: 31264319]
  29. Gynecol Oncol. 2015 Aug;138(2):317-22 [PMID: 26026733]
  30. Ci Ji Yi Xue Za Zhi. 2019 Sep 16;31(4):240-243 [PMID: 31867252]
  31. J Cancer Educ. 2020 Feb;35(1):86-92 [PMID: 30415315]
  32. J Womens Health (Larchmt). 2016 Sep;25(9):944-51 [PMID: 26890012]
  33. Cancers (Basel). 2020 Apr 24;12(4): [PMID: 32344565]
  34. BMC Womens Health. 2014 Nov 25;14:139 [PMID: 25420580]
  35. P R Health Sci J. 2012 Dec;31(4):205-12 [PMID: 23844468]
  36. Int J Environ Res Public Health. 2021 Feb 10;18(4): [PMID: 33578977]
  37. Int J Gynaecol Obstet. 2014 Aug;126(2):156-60 [PMID: 24880188]
  38. Lancet Glob Health. 2020 Feb;8(2):e191-e203 [PMID: 31812369]
  39. Can Oncol Nurs J. 2021 Jul 01;31(3):266-274 [PMID: 34395829]
  40. BMC Health Serv Res. 2017 Mar 21;17(1):222 [PMID: 28320374]
  41. J Clin Med. 2019 Jan 17;8(1): [PMID: 30658463]
  42. BMC Cancer. 2017 Nov 9;17(1):734 [PMID: 29121873]
  43. J Med Internet Res. 2020 Dec 14;22(12):e20653 [PMID: 33284782]
  44. BMC Infect Dis. 2021 May 31;21(1):504 [PMID: 34058992]
  45. Bull Cancer. 2011 Jul;98(7):723-31 [PMID: 21700548]
  46. J Womens Health (Larchmt). 2019 Mar;28(3):384-392 [PMID: 30481121]
  47. BMC Womens Health. 2022 Mar 4;22(1):58 [PMID: 35246111]
  48. J Low Genit Tract Dis. 2018 Oct;22(4):302-310 [PMID: 30179994]
  49. Cancer Nurs. 2018 Jan/Feb;41(1):45-52 [PMID: 28114260]
  50. J Med Screen. 2016 Sep;23(3):164-70 [PMID: 26919866]
Journal Article
Article has an altmetric score of 1

Word Cloud

Created with Highcharts 10.0.001screeningHPV=cervicalcancerself-samplingOR:95%CI:vaginalpacceptabilityprogramonlinesurvey2results3nrespondentsknowPapnationalamongtest7Background:Lowpatient’sadherenceconventionalmethodsdeterminedneedtakeconsiderationalternativeapproachesoneaimedevaluateusingRomanianwomen’sMethods:13-questionsdistributedthreeFacebookgroupssummarizedResults:Despitegoodeducationalbackground108%60smear33%183informedfreeMultivariateanalysisrevealedincreasedlikelihoodacceptance80062−5743102196010−380602infection35099−17449p<00167950−294803Moreoverwomenpreviouslyundergolikelyacceptnewmethod62878−3015044Conclusions:showedhighratesparticipantsAcceptabilityHumanPapillomaVirusSelf-SamplingCervicalCancerScreeningCohortPatientsRomaniaStagedetection

Similar Articles

Cited By